CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma.

Mathilde WagnerCelia AntunesDaniel PietraszChristophe CassinottoMagaly ZappaAntonio Sa CunhaOliver LucidarmeJean-Baptiste Bachet

Published in: European radiology (2016)

• Significant tumour size decreases were observed on CT after FOLFIRINOX (± chemoradiotherapy). • CT is not able to predict R0 resection accurately after FOLFIRINOX (± chemoradiotherapy). • CT is not able to predict complete response accurately after FOLFIRINOX (± chemoradiotherapy). • Even with a stable NCCN classification, BR/LA pancreatic adenocarcinoma could have R0 resection.

Keyphrases

locally advanced
rectal cancer
neoadjuvant chemotherapy
squamous cell carcinoma
image quality
dual energy
radiation therapy
phase ii study
computed tomography
contrast enhanced
positron emission tomography
machine learning
magnetic resonance
deep learning